当前位置:主页 > 医学论文 > 中医论文 >

醒脑静注射液治疗登革热的临床观察

发布时间:2018-06-21 08:33

  本文选题:登革热 + 中医疗法 ; 参考:《广州中医药大学》2016年硕士论文


【摘要】:目的:本研究观察醒脑静注射液对登革热(卫气同病证)患者的作用,通过其对中医症候积分、退热天数、白细胞计数及血小板计数的影响,评价醒脑静注射的疗效及安全性,旨在为中医药治疗登革热提供一种临床参考。方法:选取符合纳入标准的54例登革热(卫气同病证)为研究对象,随机分为治疗组和对照组,每组27例。对照组给予一般对症支持治疗:降温、静脉及口服补液、止血护胃等;治疗组加用醒脑静注射液20m静脉滴注,一天一次,疗程均为5天,使用时予0.9%氯化钠250m1或5%葡萄糖250m1稀释。观察指标:中医症候积分、退热天数、白细胞计数、血小板计数等。对比治疗组与对照组治疗前后及对照组与治疗组组间的差异。结果:1.两组患者在年龄、性别、皮疹发生情况、治疗前肝肾功能两两比较,差异无统计学意义(P0.05),具有可比性。2.两组治疗前中医症候积分组间比较,差异无统计学意义(P0.05);两组治疗后与治疗前比较,症状改善明显,差异有统计学意义(P0.05);治疗组与对照组治疗后比较,差异有统计学意义(P0.05)。3.治疗组退热天数短于对照组,两组比较,差异有统计学意义(P0.05)。4.两组治疗前白细胞计数组间比较,差异无统计学意义(P0.05);两组治疗后与治疗前比较,白细胞计数提升明显,差异有统计学意义(P0.05);治疗组与对照组治疗后比较,差异有统计学意义(P0.05)。5.两组治疗前血小板计数组间比较,差异无统计学意义(P0.05);治疗组治疗后与治疗前比较,血小板计数提升明显,差异有统计学意义(P0.05);对照组治疗后与治疗前比较,血小板计数提升不明显,差异无统计学意义(P0.05);治疗组与对照组治疗后比较,差异无统计学意义(P0.05)。结论:1.两组均可改善患者临床症状,但治疗组症状改善更明显。2.醒脑静注射液能更快使登革热(卫气同病证)患者降温,在缩短退热天数方面优于对照组。3.治疗组白细胞计数、血小板计数提升更高,治疗后白细胞计数、血小板计数平均值均高于对照组,两组治疗后两项指标数据均未超过参考值范围。4.醒脑静注射液治疗登革热具有较好的安全性。
[Abstract]:Objective: to observe the effect of Xingnaojing injection (Xingnaojing injection) on patients with dengue fever (Wei Qi syndromes syndrome), and to evaluate the efficacy and safety of Xingnaojing injection through its effect on TCM symptom score, antipyretic days, white blood cell count and platelet count. To provide a clinical reference for the treatment of dengue fever with traditional Chinese medicine. Methods: 54 cases of dengue fever were randomly divided into treatment group and control group with 27 cases in each group. The control group was given general symptomatic support therapy: cooling, intravenous and oral rehydration, hemostasis and stomach protection, and the treatment group were treated with Xingnaojing injection 20m intravenous drip once a day for 5 days. When used, 0.9% sodium chloride 250m1 or 5% glucose 250m1 were diluted. Indicators: TCM symptom score, antipyretic days, white blood cell count, platelet count, etc. The difference between the treatment group and the control group before and after treatment and between the control group and the treatment group was compared. The result is 1: 1. There was no significant difference between the two groups in age, sex, rashes, liver and kidney function before treatment, there was no significant difference between the two groups (P 0.05). There was no significant difference in the scores of TCM symptoms between the two groups before treatment, there was no significant difference between the two groups before and after treatment, the symptoms of the two groups were obviously improved after treatment and the difference was statistically significant (P 0.05), and the difference between the treatment group and the control group was statistically significant after treatment. The days of antipyretic in the treatment group was shorter than that in the control group, and the difference between the two groups was statistically significant. There was no significant difference in white blood cell count between the two groups before treatment (P 0.05); after treatment and before treatment, the white blood cell count increased significantly in the two groups, and the difference was statistically significant (P 0.05), while that in the treatment group was higher than that in the control group (P 0.05). The difference was statistically significant (P 0.05). There was no significant difference in platelet count between the two groups before treatment (P 0.05); in the treatment group, the platelet count increased significantly after treatment and before treatment, and the difference was statistically significant (P 0.05); in the control group, it was compared with that before treatment. There was no significant difference in platelet count between the treatment group and the control group (P 0.05). Conclusion 1. Both groups were able to improve the clinical symptoms, but the treatment group was more obvious. 2. 2. Xingnaojing injection can lower the temperature of patients with dengue fever faster than the control group in reducing the days of fever. The leukocyte count and platelet count in the treatment group were higher than those in the control group. After treatment, the mean white blood cell count and platelet count were higher than those in the control group, and the two indexes in both groups did not exceed the reference value range. 4. Xingnaojing injection has good safety in treating dengue fever.
【学位授予单位】:广州中医药大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R259

【参考文献】

相关期刊论文 前10条

1 Rashedul Islam;Mohammed Salahuddin;Md.Salahuddin Ayubi;Tahmina Hossain;Apurba Majumder;Andrew W.Taylor-Robinson;Abdullah Mahmud-Al-Rafat;;Dengue epidemiology and pathogenesis:images of the future viewed through a mirror of the past[J];Virologica Sinica;2015年05期

2 ;登革热诊疗指南(2014年第2版)[J];传染病信息;2014年05期

3 顾怀金;李根;万东;;醒脑静注射液治疗急性脑出血的临床疗效及对血清hs-CRP和NSE的影响[J];中国实验方剂学杂志;2014年14期

4 首云菊;;醒脑静注射液对急性酒精中毒患者氧代谢及氧化应激的影响[J];海南医学院学报;2014年10期

5 陈国栋;汪沛沛;胡志峰;;醒脑静治疗急性上呼吸道感染的疗效观察[J];辽宁医学院学报;2012年06期

6 李世泽;丁进京;史哲;;醒脑静注射液对重症脑出血患者肺部感染及细胞因子的作用[J];中国实用神经疾病杂志;2012年11期

7 沈文娟;张珂良;汪丽;贾娜;胡春丽;;对我国医疗机构制剂管理现状的思考[J];中国药事;2012年04期

8 赵君秋;王维;;醒脑静注射液对急性大面积脑梗死患者血清hs-CRP的影响[J];山东医药;2011年45期

9 史雁;;醒脑静辅助治疗卒中相关性肺炎的疗效[J];实用临床医学;2011年04期

10 党利华;王咏龙;娄芳芳;邹晓辉;;醒脑静注射液治疗病毒性脑炎伴意识障碍的疗效观察[J];现代中西医结合杂志;2011年09期

相关重要报纸文章 前1条

1 刘清泉 ;王宁;;登革热 中医辨治有道[N];健康报;2014年

相关硕士学位论文 前1条

1 王晴晴;登革热患者血清IL-12p70、IFN-γ、TNF-α、IL-6和IL-10的变化及其临床意义[D];昆明医学院;2010年



本文编号:2047906

资料下载
论文发表

本文链接:https://www.wllwen.com/zhongyixuelunwen/2047906.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户9df16***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com